The Hanover Insurance Group has been treading water for the past six months, recording a small return of 0.6% while holding steady at $178.75.

Is now the time to buy The Hanover Insurance Group, or should you be careful about including it in your portfolio? See what our analysts have to say in our full research report, it’s free.

Why Is The Hanover Insurance Group Not Exciting?

We're sitting this one out for now. Here are three reasons why THG doesn't excite us and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

In general, insurance companies earn revenue from three primary sources. The first is the core insurance business itself, often called underwriting and represented in the income statement as premiums earned. The second source is investment income from investing the “float” (premiums collected upfront not yet paid out as claims) in assets such as fixed-income assets and equities. The third is fees from various sources such as policy administration, annuities, or other value-added services.

Unfortunately, The Hanover Insurance Group’s 6.6% annualized revenue growth over the last five years was mediocre. This was below our standard for the insurance sector.

2. Net Premiums Earned Point to Soft Demand

When insurers sell policies, they protect themselves from extremely large losses or an outsized accumulation of losses with reinsurance (insurance for insurance companies). Net premiums earned are therefore net of what’s ceded to reinsurers as a risk mitigation and transfer strategy.

The Hanover Insurance Group’s net premiums earned has grown at a 4.3% annualized rate over the last two years, worse than the broader insurance industry and in line with its total revenue.

3. Growing BVPS Reflects Strong Asset Base

In the insurance industry, book value per share (BVPS) provides a clear picture of shareholder value, as it represents the total equity backing a company’s insurance operations and growth initiatives.

Although The Hanover Insurance Group’s BVPS increased by a meager 2.8% annually over the last five years, the good news is that its growth has recently accelerated as BVPS grew at an excellent 21% annual clip over the past two years (from $68.87 to $100.89 per share).

Final Judgment

The Hanover Insurance Group isn’t a terrible business, but it doesn’t pass our quality test. That said, the stock currently trades at 1.6× forward P/B (or $178.75 per share). This valuation multiple is fair, but we don’t have much faith in the company. We're pretty confident there are more exciting stocks to buy at the moment. We’d suggest looking at a top digital advertising platform riding the creator economy.

Stocks We Would Buy Instead of The Hanover Insurance Group

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.